J. Goldman & Co’s CalciMedica CALC Stock Holding History

J. Goldman & Co’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-18,900	Closed	-$125K	–	684
2025 Q4	$125K	Hold	18,900	–	–	﹤0.01%	528
2025 Q3	$58.1K	Hold	18,900	–	–	﹤0.01%	433
2025 Q2	$30.2K	Hold	18,900	–	–	﹤0.01%	433
2025 Q1	$36.1K	Hold	18,900	–	–	﹤0.01%	456
2024 Q4	$66.9K	Hold	18,900	–	–	﹤0.01%	424
2024 Q3	$83.7K	Hold	18,900	–	–	﹤0.01%	431
2024 Q2	$74.8K	Buy	+18,900	New	+$95.2K	﹤0.01%	416

Other funds holding CALC

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

SFFS

Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

J. Goldman & Co's CALC Position: Q1 2026 in Review

J. Goldman & Co sold out of CalciMedica (CALC) in Q1 2026, closing a stake of 18,900 shares — an estimated $125K sold.

J. Goldman & Co first reported a position in CALC in Q2 2024 and held it in 7 quarters. The position peaked at $125K in Q4 2025. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

J. Goldman & Co reported no remaining CalciMedica position as of Q1 2026 after selling out during the quarter.
J. Goldman & Co sold 18,900 CalciMedica shares in Q1 2026, an estimated $125K.
J. Goldman & Co first reported a position in CalciMedica in Q2 2024 and held it in 7 quarters.
J. Goldman & Co's CalciMedica position peaked at $125K in Q4 2025.
27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.